← Leaderboards
Mark D McCauley
University Of Illinois At Chicago
$4,386,614
Attributed
$5,056,207
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $970.4K · FY2016–24$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,056,207 · 3
VA$0 · 1
By mechanism
R01$3,159,577 · 1
R38$1,004,390 · 1
K08$892,240 · 1
I01$0 · 1
Top collaborators
- Steven M Dudek3 shared
- Jeffrey R Jacobson3 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- R John Solaro$27,541,486
- Pieter P. De Tombe$10,557,531
- Karyn Ann Esser$18,858,503
- Jordi Cabana$2,868,365
- Nina Orlovskaya$2,162,791
Others in their field
Top investigators on “Arrhythmia”
- Dan M Roden · Vanderbilt University Medical Center$63,173,998
- Lynn A Sleeper · New England Research Institutes, Inc.$48,939,627
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$40,886,752
- Russell E Ware · Duke University$30,715,534
- David Herlie Robertson · Vanderbilt University$28,928,663
- Henry R Halperin · Johns Hopkins University$27,245,374
Research focus
ArrhythmiaCause Of DeathCardiacChronicSignal TransductionInnovationPredispositionPathologicMicrofilamentsPhosphorylationHeart AtriumIn VivoMyosin Light ChainsGeneticMouse ModelAtrial FibrillationFunctional DisorderBloodHeartAuricular AppendageIn VitroBaseBindingHeart Diseases
Grant awards (17)
Myosin Light Chain Dephosphorylation by PPP1R12C Promotes Atrial Hypocontractility and Atrial Fibrillation$626,075
R01 · FY2024 · HL · contact PI
Fostering Academic Physician-Investigators Treating High Risk Populations$333,296
R38 · FY2024 · HL
In Vivo Restoration of Myocardial Conduction with Carbon Nanotube Fibers$0
I01 · FY2024 · VA · contact PI
Myosin Light Chain Dephosphorylation by PPP1R12C Promotes Atrial Hypocontractility and Atrial Fibrillation$634,873
R01 · FY2023 · HL · contact PI
Fostering Academic Physician-Investigators Treating High Risk Populations$335,547
R38 · FY2023 · HL
In Vivo Restoration of Myocardial Conduction with Carbon Nanotube Fibers$0
I01 · FY2023 · VA · contact PI
Myosin Light Chain Dephosphorylation by PPP1R12C Promotes Atrial Hypocontractility and Atrial Fibrillation$631,035
R01 · FY2022 · HL · contact PI
Fostering Academic Physician-Investigators Treating High Risk Populations$335,547
R38 · FY2022 · HL
In Vivo Restoration of Myocardial Conduction with Carbon Nanotube Fibers$0
I01 · FY2022 · VA · contact PI
Myosin Light Chain Dephosphorylation by PPP1R12C Promotes Atrial Hypocontractility and Atrial Fibrillation$627,331
R01 · FY2021 · HL · contact PI
In Vivo Restoration of Myocardial Conduction with Carbon Nanotube Fibers$0
I01 · FY2021 · VA · contact PI
Myosin Light Chain Dephosphorylation by PPP1R12C Promotes Atrial Hypocontractility and Atrial Fibrillation$640,263
R01 · FY2020 · HL · contact PI
PPP1R12C contributes to myosin light chain de-phosphorylation and atrial hypocontractility in atrial fibrillation$178,448
K08 · FY2020 · HL · contact PI
PPP1R12C contributes to myosin light chain de-phosphorylation and atrial hypocontractility in atrial fibrillation$178,448
K08 · FY2019 · HL · contact PI
PPP1R12C contributes to myosin light chain de-phosphorylation and atrial hypocontractility in atrial fibrillation$178,448
K08 · FY2018 · HL · contact PI
PPP1R12C contributes to myosin light chain de-phosphorylation and atrial hypocontractility in atrial fibrillation$178,448
K08 · FY2017 · HL · contact PI
PPP1R12C contributes to myosin light chain de-phosphorylation and atrial hypocontractility in atrial fibrillation$178,448
K08 · FY2016 · HL · contact PI